Some physicians advocate repeating the duplex venous ultrasound in patients with an initial negative test result, if the suspicion for DVT remains. Two studies with a total of 2107 patients repeated the ultrasound 5 to 7 days later, if the first ultrasound result was normal; patients with 2 normal ultrasound results did not receive anticoagulation.22,23 Only 0.6% of these patients had a thromboembolic complication (DVT or pulmonary embolism) during the next 3 months, and only 1 of these occurred during the week between ultrasounds. A third study repeated the ultrasound 1 day and again 6 days later in patients with a normal initial ultrasound results.24 Of 390 patients with 3 normal ultrasound results, only 6 had a thromboembolic complication during the next 3 months. Thus, in patients with 2 normal results 1 week apart, the risk of a thromboembolic complication during the next 3 months is approximately 1%.
D-dimer is a fibrin degradation product, and elevated levels are associated with an increased risk of DVT. Different d-dimer assays vary considerably in their performance. Latex agglutination assays are fast and cheap but not very accurate; they are therefore not recommended. Microplate enzyme-linked immunoassays (ELISAs) are accurate but expensive; membrane ELISAs are less expensive and nearly as accurate. The accuracy of one of the most widely used d-dimer tests (SimpliRED) is shown in Table 3. Note that a negative d-dimer test rersult alone does not rule out DVT; 2% to 5% of patients with suspected DVT and a negative d-dimer result actually have DVT. This is similar to the performance of ultrasound alone in unselected patients with suspected DVT. Because of the differences between tests, clinicians should learn which test is used by their laboratory and should advocate for use of the most accurate available test.
The d-dimer test is most useful in a patient with a moderate risk of DVT and a normal duplex venous ultrasound result. In one study, only 1 of 598 patients with normal ultrasound and normal d-dimer test results (membrane ELISA; Instant-IA d-dimer kit, Stago, Asnieres, France) developed a DVT in the next 3 months. Of 88 patients with normal duplex venous ultrasound results but elevated d-dimer levels, 5 had a DVT detected 1 week later with a repeat ultrasound, and an additional 2 had venous thromboembolic complications during the next 3 months.25
Approaching the patient
Evaluating all patients with suspected DVT in the same way risks overdiagnosing low-risk patients and underdiagnosing high-risk patients. The history and physical examination can guide the selection and interpretation of further diagnostic tests. Begin by using the Wells clinical decision rule Figure 1 to put the patient in the low-, moderate-, or high-risk group. Remember that this rule was developed in nonpregnant patients with a first DVT. For pregnant patients or those with a history of previous DVT, you should have a higher index of suspicion.
Next, use the algorithm in Figure 2 to guide your evaluation. DVT can be considered adequately ruled out in low-risk patients with a negative ultrasound result and in moderate-risk patients with normal d-dimer and normal ultrasound results. Moderate-risk patients with a normal initial result on ultrasound but an abnormal d-dimer level should have a repeat ultrasound in 1 week. Moderate- and high-risk patients with an abnormal ultrasound result should be treated for DVT. High-risk patients with a normal ultrasound result still have a fairly high probability of DVT and should have a venogram to establish the diagnosis. In high-risk patients normal ultrasound and normal d-dimer results do not adequately rule out DVT.
Of course, this algorithm should not be used inflexibly. Patients with new or progressive symptoms (eg, a person with suspected DVT who develops signs and symptoms of PE) should be evaluated immediately. Pregnant patients and patients with a history of DVT should be evaluated more aggressively, because their overall risk of DVT is higher.
All correspondence should be addressed to Mark H. Ebell, MD, MS, 330 Snapfinger Drive, Athens, GA 30605. E-mail: ebell@msu.edu.